Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Salted Surgical Mask Deactivates Aerosol Viruses

By HospiMedica International staff writers
Posted on 18 Jan 2017
A novel salt coating on the fiber surface of a surgical mask dissolves upon exposure to virus aerosols and recrystallizes during drying, destroying the pathogens.

Developed by researchers at the University of Alberta and Kyung Hee University, the universal, reusable virus deactivation system is based on common sodium chloride salt that coats the fibrous filtration unit of the surgical mask. More...
When an aerosol droplet carrying the influenza virus contacts the treated filter, the droplet absorbs the salt on the filter. The virus is exposed to increasing concentrations of salt as the droplet evaporates, suffering fatal physical damage when the salt returns to its crystalized state.

In a series of experiments, viruses captured on the salt-coated filters show a rapid decrease in infectivity compared to a more gradual decrease when placed on bare filters. The salt-coated filters proved especially effective in deactivating influenza viruses, regardless of subtypes and even following storage in harsh environmental conditions. The researchers suggest that the technique can be applied in broad-spectrum, airborne pathogen prevention devices in preparation for combatting epidemic and pandemic respiratory diseases. The study was published on January 4, 2017, in Scientific Reports.

“Our salt-coated filter unit can promise the development of long-term, stable, versatile airborne pathogen negation systems, without safety concerns,” said Professor Hyo-Jick Choi, PhD, of the University of Alberta department of chemical and materials engineering. “We believe that salt-recrystallization based virus deactivation system can contribute to global health by providing a more reliable means of preventing transmission and infection of pandemic or epidemic diseases and bioterrorism.”

Past experiences with severe acute respiratory syndrome (SARS), H1N1 swine influenza, and Middle East respiratory syndrome (MERS) indicate that surgical masks are widely adopted by the public as a personal protective measure, despite an ongoing controversy on their effectiveness. However, in the lack of a system to deactivate the collected pathogens, safety concerns naturally arise about secondary infection and contamination from virus-laden filter media during utilization and disposal. The main alternative, the N95 respirator, requires training prior to use, must be expertly fitted to address the risk of face seal leakage, and must be disposed of as biohazard.


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.